William Raine Craig

William Raine Craig

Auto-generated profile, based on publicly available information

William Raine Craig

Department of Pediatrics, University of Alberta, Edmonton, Canada

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in The Lancet Neurology
Verified
Journal Article
Closed access
AMAndrew I R Maas
Andrew I R Maas
DMDavid K Menon
David K Menon
PAP David Adelson
P David Adelson
NANada Andelic
Nada Andelic
MBMichael J Bell
Michael J Bell
FZFabrizio Zumbo
Fabrizio Zumbo

8 March 2016 in JAMA
Verified
Journal Article
Closed access
PDF file
RZRoger Zemek
Roger Zemek
NBNick Barrowman
Nick Barrowman
SFStephen Freedman
Stephen Freedman
JGJocelyn Gravel
Jocelyn Gravel
IGIsabelle Gagnon
Isabelle Gagnon
FTfor the Pediatric Emergency Research Canada (PERC) Concussion Team
for the Pediatric Emergency Research Canada (PERC) Concussion Team
Research from JAMA — Clinical Risk Score for Persistent Postconcussion Symptoms Among Children With Acute Concussion in the ED

1 January 2019 in JAMA Pediatrics
Verified
Journal Article
Closed access
PDF file
ALAndrée-Anne Ledoux
Andrée-Anne Ledoux
KTKen Tang
Ken Tang
KYKeith O. Yeates
Keith O. Yeates
MPMartin V. Pusic
Martin V. Pusic
KBKathy Boutis
Kathy Boutis
FTfor the Pediatric Emergency Research Canada (PERC) Concussion Team
for the Pediatric Emergency Research Canada (PERC) Concussion Team
Importance The natural progression of symptom change and recovery remains poorly defined in children after concussion. Objectives To describe the natural progression of symptom change by age group (5-7, 8-12, and 13-18 years) and sex, as well as to develop centile curves to inform families about children after injury recovery. Design, Setting, and Participants Planned secondary analysis of a prospective multicenter cohort study (Predicting Persistent Postconcussive Problems in Pediatrics). The setting was 9 pediatric emergency departments within the Pediatric Emergency Research Canada (PERC) network. Participants were aged 5 to 18 years with acute concussion, enrolled from August 1, 2013, to May 31, 2015, and data analyses were performed between January 2018 and March 2018. Exposures Participants had a concussion consistent with the Zurich Consensus Statement on Concussion in Sport diagnostic criteria and 85% completeness of the Postconcussion Symptom Inventory (PCSI) at each time point. Main Outcomes and Measures The primary outcome was symptom change, defined as current rating minus preinjury rating (delta score), at presentation and 1, 2, 4, 8, and 12 weeks after injury, measured using the PCSI. Symptoms were self-rated for ages 8 to 18 years and rated by the child and parent for ages 5 to 7 years. The secondary outcome was recovery, defined as no change in symptoms relative to current preinjury PCSI ratings (delta score = 0). Mixed-effects models incorporated the total score, adjusting for random effects (site and participant variability), fixed-effects indicators (age, sex, time, age by time interaction, and sex by time interaction), and variables associated with recovery. Recovery centile curves by age and sex were computed. Results A total of 3063 children (median age, 12.0 years [interquartile range, 9.2-14.6 years]; 60.7% male) completed the primary outcome; 2716 were included in the primary outcome analysis. For the group aged 5 to 7 years, symptom change primarily occurred the first week after injury; by 2 weeks, 75.6% of symptoms had improved (PCSI change between 0 and 2 weeks, −5.3; 95% CI, −5.5 to −5.0). For the groups aged 8 to 12 years and 13 to 18 years, symptom change was prominent the first 2 weeks but flattened between 2 and 4 weeks. By 4 weeks, 83.6% and 86.2% of symptoms, respectively, had improved for the groups aged 8 to 12 years (PCSI change between 0 and 4 weeks, −9.0; 95% CI, −9.6 to −8.4) and 13 to 18 years (PCSI change between 0 and 4 weeks, −28.6; 95% CI, −30.8 to −26.3). Sex by time interaction was significant only for the adolescent group (β = 0.32; 95% CI, 0.21-0.43;P < .001). Most adolescent girls had not recovered by week 12. Conclusions and Relevance Symptom improvement primarily occurs in the first 2 weeks after concussion in children and in the first 4 weeks after concussion in preadolescents and male adolescents. Female adolescents appear to have protracted recovery. The derived recovery curves may be useful for evidence-based anticipatory guidance.

27 May 1998 in JAMA
Verified
Journal Article
Closed access
PDF file
TKTerry P. Klassen
Terry P. Klassen
WCWilliam R. Craig
William R. Craig
DMDavid Moher
David Moher
MOMartin H. Osmond
Martin H. Osmond
HPHans Pasterkamp
Hans Pasterkamp
PRPeter C. Rowe
Peter C. Rowe
Research from JAMA — Nebulized Budesonide and Oral Dexamethasone for Treatment of Croup — A Randomized Controlled Trial — Context.—The effectiveness of glucocorticoids for patients with croup is well established but it remains uncertain which glucocorticoid regimen is most effective.Objective.—To determine the effectiveness of 3 glucocorticoid regimens in patients with croup.Design.—Randomized controlled trial with parallel design.Setting.—Emergency departments of 2 Canadian pediatric tertiary care hospitals.Participants.—Children with a clinical syndrome consistent with croup, aged 3 months to 5 years, with a croup score of 2 or greater following at least 15 minutes of mist therapy.Interventions.—Oral dexamethasone, 0.6 mg/kg, and nebulized placebo; oral placebo and nebulized budesonide, 2 mg; or oral dexamethasone, 0.6 mg/kg, and nebulized budesonide, 2 mg.Main Outcome Measures.—Westley croup score (primary outcome), hospital admission rates, time spent in the emergency department, return visits to the emergency department, or ongoing symptoms at 1 week.Results.—The mean change in the croup score from baseline to the final study assessment was −2.3 (95% confidence interval [CI], −2.6 to −2.0) in the budesonide group (n=65), −2.4 (95% CI, −2.6 to −2.2) in the dexamethasone group (n=69), and −2.4 (95% CI, −2.7 to −2.1) in the budesonide and dexamethasone group (n=64, P=.70).Conclusions.—Based on the similar outcomes in the 3 groups, oral dexamethasone is the preferred intervention because of its ease of administration, lower cost, and more widespread availability.

1 August 2006 in Academic Emergency Medicine
Verified
Journal Article
Open access
PDF file
BRBrian H. Rowe
Brian H. Rowe
PCPeter Channan
Peter Channan
MBMichael Bullard
Michael Bullard
SBSandra Blitz
Sandra Blitz
LSL. Duncan Saunders
L. Duncan Saunders
BHBrian R. Holroyd
Brian R. Holroyd
Objectives: Patients leaving the emergency department (ED) without being seen (LWBS) by a physician have become a growing concern in overcrowded EDs. The purpose of this study was to determine the acuity level, reasons, and outcomes of LWBS cases. Methods: LWBS patients (or their guardians) from two linked Canadian EDs (one adult, one pediatric), identified during 11 sampling periods of seven days' duration each, were contacted by telephone. Descriptive statistics are provided. Results: A total of 711 (4.5%) of 15,660 registered emergency patients left without being seen (50% male; median age, 33 years). Triage‐matched controls waited a median of 87 minutes before seeing a physician. Of the 711 LWBS cases, 512 (72%) were contacted and 498 agreed to participate. The most common major reason for leaving was “fed up with waiting” (44.8%). Overall, 60% of LWBS cases sought medical attention within one week; 14 patients were hospitalized, and one required urgent surgery. Triage level was not associated with the probability of subsequently seeking medical attention (61%, 61%, and 60% in triage levels 3, 4, and 5, respectively). Of the 198 (39%) who did not subsequently seek medical attention, 50 patients (26%) had been triaged as urgent and one patient died six days after ED registration. Conclusions: The most common reason for LWBS is impatience during peak ED periods. Many of these patients seek medical care within one week. Complications occurred rarely; however, “high‐risk” patients who leave without being seen do experience adverse health outcomes. Further research is required to examine ways to reduce LWBS cases.

1 April 2008 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
JRJoan Louise Robinson
Joan Louise Robinson
BLBonita E. Lee
Bonita E. Lee
SKSushma Kothapalli
Sushma Kothapalli
WCWilliam R. Craig
William R. Craig
JFJulie D. Fox
Julie D. Fox
Background. Nasopharyngeal (NP) specimens are commonly used for the detection of respiratory viruses, but throat and saliva specimens are easier to o